BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

Clinical trial NCT00632749 · COMPLETED

Trial details

NCT number: NCT00632749
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2008-05-01
Primary completion: 2014-03-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.